If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 9 Similar Profiles
Tenofovir Medicine & Life Sciences
HIV Medicine & Life Sciences
efavirenz Medicine & Life Sciences
Cryptococcal Meningitis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Lamivudine Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
GTP-Binding Protein Regulators Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2023

Research Output 2010 2019

4 Citations (Scopus)

Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial

ASTRO-CM Team, Aug 1 2019, In : The Lancet Infectious Diseases. 19, 8, p. 843-851 9 p.

Research output: Contribution to journalArticle

Cryptococcal Meningitis
Amphotericin B

Case report: Three's a crowd: A case report examining the diagnostic and pharmacokinetic challenges in hiv-tuberculous meningitis-malaria co-infection [version 2; referees: 2 approved]

Ellis, J., Eneh, P. C., Ssebambulidde, K., Rutakingirwa, M. K., Lamorde, M., Rhein, J. R., Cresswell, F. V., Boulware, D. R. & Nicol, M. R., Jan 1 2019, In : Wellcome Open Research. 3, 111.

Research output: Contribution to journalArticle

Open Access
Meningeal Tuberculosis

Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis

Nicol, M. R., Pastick, K. A., Taylor, J., Namuju, O. C., Rhein, J. R., Williams, D. A., Meya, D. B., Boulware, D. R. & Lukande, R., Sep 1 2019, In : Clinical and translational science. 12, 5, p. 445-449 5 p.

Research output: Contribution to journalArticle

Open Access
Cryptococcal Meningitis
Cerebrospinal fluid

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model

Chesdachai, S., Rajasingham, R., Nicol, M. R., Meya, D. B., Bongomin, F., Abassi, M., Skipper, C., Kwizera, R., Rhein, J. & Boulware, D. R., Sep 30 2019, In : Open Forum Infectious Diseases. 6, 10, ofz369.

Research output: Contribution to journalArticle

Open Access
Microbial Sensitivity Tests
Area Under Curve

Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States

Adams, J. L., Shelley, K. & Nicol, M. R., Apr 1 2019, In : Pharmacotherapy. 39, 4, p. 486-500 15 p.

Research output: Contribution to journalReview article

Cost-Benefit Analysis
Pre-Exposure Prophylaxis